Listen to our investment experts discuss various topics - from general investing to alternatives and much more.
In this episode, David Lebovitz, Global Strategist, Multi-Asset Solutions, is joined by Stephen Squinto, Chief Investment Officer, J.P. Morgan Life Sciences Private Capital, to discuss the alternative investment landscape, the private biotech market and areas of opportunity in 2024 and beyond.
While the 60/40 portfolio has seen a renewed focus, allocations to private markets continue to play an important role in diversification and growth. In this episode, David Lebovitz, Global Market Strategist, talks with Michael Cembalest, Chairman of Market and Investment Strategy, about the key insights featured in his biennial review of alternative investments, It's Mostly a Paper Moon.
Our experts discuss their 2024 investment predictions across equities, fixed income and alternatives.
David Lebovitz, Global Market Strategist, Multi-Asset Solutions and Jared Gross, Head of Institutional Portfolio Strategy, conduct their annual asset allocation draft across various asset classes, and make their picks for the most promising investment opportunities in 2023.
Dive into public and private market insights with JP Morgan experts on our latest podcast.
Listen to David Lebovitz and Jared Gross discuss public and private equity markets.
Our experts discuss the convergence of public and private real estate markets.
Our experts discuss the convergence of public and private credit markets.